AbstractNeuroleptic malignant syndrome (NMS) is a rare, life‐threatening complication of antipsychotic drug treatment. Its pathophysiology is controversial, and the same is true for the findings in post‐mortem studies on central nervous system pathology. In this report we present a patient who died two and a half months after suffering NMS. The findings in a thorough neuropathological examination were normal suggesting that the postulated dopamine receptor blockade in NMS is not associated with a structural central nervous system dam
展开▼